Cargando…
Prevention of Cytotoxic T Cell Escape Using a Heteroclitic Subdominant Viral T Cell Determinant
High affinity antigen-specific T cells play a critical role during protective immune responses. Epitope enhancement can elicit more potent T cell responses and can subsequently lead to a stronger memory pool; however, the molecular basis of such enhancement is unclear. We used the consensus peptide-...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2563037/ https://www.ncbi.nlm.nih.gov/pubmed/18949029 http://dx.doi.org/10.1371/journal.ppat.1000186 |
_version_ | 1782159790443593728 |
---|---|
author | Butler, Noah S. Theodossis, Alex Webb, Andrew I. Nastovska, Roza Ramarathinam, Sri Harsha Dunstone, Michelle A. Rossjohn, Jamie Purcell, Anthony W. Perlman, Stanley |
author_facet | Butler, Noah S. Theodossis, Alex Webb, Andrew I. Nastovska, Roza Ramarathinam, Sri Harsha Dunstone, Michelle A. Rossjohn, Jamie Purcell, Anthony W. Perlman, Stanley |
author_sort | Butler, Noah S. |
collection | PubMed |
description | High affinity antigen-specific T cells play a critical role during protective immune responses. Epitope enhancement can elicit more potent T cell responses and can subsequently lead to a stronger memory pool; however, the molecular basis of such enhancement is unclear. We used the consensus peptide-binding motif for the Major Histocompatibility Complex molecule H-2K(b) to design a heteroclitic version of the mouse hepatitis virus-specific subdominant S598 determinant. We demonstrate that a single amino acid substitution at a secondary anchor residue (Q to Y at position 3) increased the stability of the engineered determinant in complex with H-2K(b). The structural basis for this enhanced stability was associated with local alterations in the pMHC conformation as a result of the Q to Y substitution. Recombinant viruses encoding this engineered determinant primed CTL responses that also reacted to the wildtype epitope with significantly higher functional avidity, and protected against selection of virus mutated at a second CTL determinant and consequent disease progression in persistently infected mice. Collectively, our findings provide a basis for the enhanced immunogenicity of an engineered determinant that will serve as a template for guiding the development of heteroclitic T cell determinants with applications in prevention of CTL escape in chronic viral infections as well as in tumor immunity. |
format | Text |
id | pubmed-2563037 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-25630372008-10-24 Prevention of Cytotoxic T Cell Escape Using a Heteroclitic Subdominant Viral T Cell Determinant Butler, Noah S. Theodossis, Alex Webb, Andrew I. Nastovska, Roza Ramarathinam, Sri Harsha Dunstone, Michelle A. Rossjohn, Jamie Purcell, Anthony W. Perlman, Stanley PLoS Pathog Research Article High affinity antigen-specific T cells play a critical role during protective immune responses. Epitope enhancement can elicit more potent T cell responses and can subsequently lead to a stronger memory pool; however, the molecular basis of such enhancement is unclear. We used the consensus peptide-binding motif for the Major Histocompatibility Complex molecule H-2K(b) to design a heteroclitic version of the mouse hepatitis virus-specific subdominant S598 determinant. We demonstrate that a single amino acid substitution at a secondary anchor residue (Q to Y at position 3) increased the stability of the engineered determinant in complex with H-2K(b). The structural basis for this enhanced stability was associated with local alterations in the pMHC conformation as a result of the Q to Y substitution. Recombinant viruses encoding this engineered determinant primed CTL responses that also reacted to the wildtype epitope with significantly higher functional avidity, and protected against selection of virus mutated at a second CTL determinant and consequent disease progression in persistently infected mice. Collectively, our findings provide a basis for the enhanced immunogenicity of an engineered determinant that will serve as a template for guiding the development of heteroclitic T cell determinants with applications in prevention of CTL escape in chronic viral infections as well as in tumor immunity. Public Library of Science 2008-10-24 /pmc/articles/PMC2563037/ /pubmed/18949029 http://dx.doi.org/10.1371/journal.ppat.1000186 Text en Butler et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Butler, Noah S. Theodossis, Alex Webb, Andrew I. Nastovska, Roza Ramarathinam, Sri Harsha Dunstone, Michelle A. Rossjohn, Jamie Purcell, Anthony W. Perlman, Stanley Prevention of Cytotoxic T Cell Escape Using a Heteroclitic Subdominant Viral T Cell Determinant |
title | Prevention of Cytotoxic T Cell Escape Using a Heteroclitic Subdominant Viral T Cell Determinant |
title_full | Prevention of Cytotoxic T Cell Escape Using a Heteroclitic Subdominant Viral T Cell Determinant |
title_fullStr | Prevention of Cytotoxic T Cell Escape Using a Heteroclitic Subdominant Viral T Cell Determinant |
title_full_unstemmed | Prevention of Cytotoxic T Cell Escape Using a Heteroclitic Subdominant Viral T Cell Determinant |
title_short | Prevention of Cytotoxic T Cell Escape Using a Heteroclitic Subdominant Viral T Cell Determinant |
title_sort | prevention of cytotoxic t cell escape using a heteroclitic subdominant viral t cell determinant |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2563037/ https://www.ncbi.nlm.nih.gov/pubmed/18949029 http://dx.doi.org/10.1371/journal.ppat.1000186 |
work_keys_str_mv | AT butlernoahs preventionofcytotoxictcellescapeusingaheterocliticsubdominantviraltcelldeterminant AT theodossisalex preventionofcytotoxictcellescapeusingaheterocliticsubdominantviraltcelldeterminant AT webbandrewi preventionofcytotoxictcellescapeusingaheterocliticsubdominantviraltcelldeterminant AT nastovskaroza preventionofcytotoxictcellescapeusingaheterocliticsubdominantviraltcelldeterminant AT ramarathinamsriharsha preventionofcytotoxictcellescapeusingaheterocliticsubdominantviraltcelldeterminant AT dunstonemichellea preventionofcytotoxictcellescapeusingaheterocliticsubdominantviraltcelldeterminant AT rossjohnjamie preventionofcytotoxictcellescapeusingaheterocliticsubdominantviraltcelldeterminant AT purcellanthonyw preventionofcytotoxictcellescapeusingaheterocliticsubdominantviraltcelldeterminant AT perlmanstanley preventionofcytotoxictcellescapeusingaheterocliticsubdominantviraltcelldeterminant |